Loans to European and Asian countries from the International Monetary Fund (IMF) are associated with significantly higher tuberculosis rates and mortality, according to a study published in PLoS Medicine and co–authored by a doctoral student at the Yale School of Public Health.
The researchers examined 21 post–communist countries in Europe and the former Soviet Union and found that IMF loan programs were associated with a 16.6 percent increase in TB mortality. Strict conditions placed on IMF loans in those countries resulted in cuts to health and education budgets when countries have to repay the loans, according to Sanjay Basu, M.D, a PhD candidate at Yale, and his co–authors David Stuckler and Lawrence King of Cambridge University in England.
The findings are particularly troubling because drug–resistant forms of tuberculosis are spreading and more treatment is needed, the authors said.
“There were significant declines in the number of doctors available to treat tuberculosis,” in countries receiving IMF loans, Basu said. “Soon after the countries entered the IMF programs, there was a significant rise in tuberculosis cases and deaths. The rates were stable or improving beforehand. When countries left the IMF programs, their rates of tuberculosis significantly improved.”